Construction of a Prognostic Immune-Related LncRNA Risk Model for Gastric Cancer

Table 4

Univariate and multivariate analysis of disease-free survival.

	Univariate analysis			Multivariate analysis
	HR	Upper 95	value	HR	Upper 95	value
Tumor stage (early vs. advance)	0.477	[0.298–0.763]	0.010	0.549	[0.357–0.843]	0.006
Risk score (low vs. high)	0.563	[0.364–0.871]	0.002	0.492	[0.308–0.785]	0.003
Age (years)	1.671	[1.025–2.723]	0.040	1.647	[1.014–2.674]	0.044
Differentiated degree (low vs. high)	0.851	[0.548–1.322]	0.472	—	—	—
Gender (female vs. male)	1.001	[0.981–1.021]	0.945	—	—	—

Note: HR = hazard ratio; CI = confidence interval; statistically significant.